Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Queen's Scientific Breakthrough Fund (QSBF) is a venture capital investment vehicle established by Queen's University Belfast to support the commercialization of research-led innovations. The fund specifically targets early-stage spin-out companies originating from the university, with a heavy emphasis on the life sciences, healthcare, and physical sciences sectors. Managed by QUBIS, the university's commercialization arm, QSBF provides essential seed capital to bridge the gap between academic proof-of-concept and institutional venture investment. By leveraging the university's world-class research base, the fund aims to foster a vibrant ecosystem of high-growth technology companies in Northern Ireland. QSBF works in conjunction with external investment partners and government-backed initiatives to maximize the impact of its portfolio companies. The fund's strategic focus includes therapeutic development, medical devices, and digital health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Queen's Scientific Breakthrough Fund.